Rodman David Malcom sold MLYS
April 15, 2026 · Form 4 insider transaction
Rodman David Malcom sold 6,348 shares of Mineralys Therapeutics, Inc. at $27.66 per share, a transaction worth $175.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,348
Price
$27.66
Total value
$175.6K
InsiderRodman David Malcom
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 15, 2026
Filing dateApril 15, 2026
Shares owned after69,792
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.